Company initiatives
-
BioAmber phases out E.coli use
.
The blog is just catching up with some of the earnings conference calls from last week. Here are some highlighted information from BioAmber. I am also checking out Codexis, Cereplast and Syntroleum if they have any interesting updates for the…
-
New bio-butanol player: Optinol
.
There’s a new kid in the bio-butanol town. I saw this press release last night while I was going through my newsfeed and this is the first time I’ve heard of San Francisco-based Optinol — a collaborative venture between SynGest…
-
Big green news from last week
.
I am back from my vacation and trying to delete/answer hundreds of emails from the past 10 days. Meanwhile, let me posts these news from last week before I start completing my presentation for next month’s ICIS World Chemical Purchasing…
-
Amyris lowers farnesene costs
.
This will be my last post for the week before I venture off to my week-long vacation (Woohoo!). The blog gets some update late Thursday from Amyris’ second quarter earnings report and conference call. One of the major highlight of…
-
INTERVIEW: OPXBIO starts funding round
.
It has been more than a year since the blog had the pleasure of again chatting with OPX Biotechnologies (OPXBIO) CEO Charles Eggert. Last Tuesday, Eggert mentioned that the company has started this month their plans to raise their fourth…
-
Solazyme launches new anti-aging algal oil
.
Solazyme has launched a new anti-aging serum product under its anti-aging skin care brand Algenist. The serum Advanced Anti-Aging Repairing Oil, which features Solazyme’s microalgae oil enriched with oleic acid, is now available internationally on store shelves at Sephora, JCPenney,…
-
Amyris to get $60m funding from Temasek
.
Amyris has entered a deal for the sale of convertible notes in a private placement for up to $60 million in cash proceeds. Amyris’s largest stockholders, Temasek, agreed to purchase $35 million of the notes in an initial tranche and, at…